Review Article
Molecular mechanisms of curcumin action: Signal transduction
Adeeb Shehzad,
Young Sup Lee,
Adeeb Shehzad
School of Life Sciences, College of Natural Sciences, Kyungpook National University, Daegu 702-701, Korea
Search for more papers by this authorCorresponding Author
Young Sup Lee
School of Life Sciences, College of Natural Sciences, Kyungpook National University, Daegu 702-701, Korea
Tel.: +82-53-950-6353; Fax: +82-53-943-2762
School of Life Sciences, College of Natural Sciences, Kyungpook National University, 1370 Sangeok-dong, Buk-ku, Daegu 702-701, KoreaSearch for more papers by this author
Adeeb Shehzad,
Young Sup Lee,
Adeeb Shehzad
School of Life Sciences, College of Natural Sciences, Kyungpook National University, Daegu 702-701, Korea
Search for more papers by this authorCorresponding Author
Young Sup Lee
School of Life Sciences, College of Natural Sciences, Kyungpook National University, Daegu 702-701, Korea
Tel.: +82-53-950-6353; Fax: +82-53-943-2762
School of Life Sciences, College of Natural Sciences, Kyungpook National University, 1370 Sangeok-dong, Buk-ku, Daegu 702-701, KoreaSearch for more papers by this authorAbstract
Chemoprevention represents one of the most highly effective anti-cancer strategies and is accompanied by minimal secondary effects as compared to conventional chemotherapies. Many new anti-inflammatory and anti-cancer drug candidates have been derived from chemical scaffolds engineered from natural products discovered just a few decades ago. This approach is widely utilized in drug discovery in order to produce novel molecular entities with enhanced drug activities mediated through various signal transduction pathways for the treatment of different diseases. Curcumin, a polyphenolic derivative of turmeric, is a naturally occurring compound isolated from Curcuma longa that suppresses and inverts carcinogenesis via multifaceted molecular targets. Several reports have demonstrated that curcumin inhibits animal and human cancers, suggesting that it may serve as a chemopreventive agent. Numerous in vitro and in vivo experimental models have also revealed that curcumin regulates several molecules in cell signal transduction pathway including NF-κB, Akt, MAPK, p53, Nrf2, Notch-1, JAK/STAT, β-catenin, and AMPK. Modulation of cell signaling pathways through the pleiotropic effects of curcumin likely activate cell death signals and induce apoptosis in cancer cells, thereby inhibiting the progression of disease. This article provides insights into the natural chemopreventive role of curcumin via cellular transduction pathways and provides an in depth assessment of its physiological activities in the management of diseases. © 2013 BioFactors, 39(1):27–36, 2013
References
- 1 Li, N., Chen, X., Liao, J., Yang, G., Wang, S., et al. ( 2002) Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23, 1307–1313.
- 2 Aggarwal, B. B., Kumar, A., and Bharti, A. C. ( 2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363–398.
- 3 Ravindran, J., Prasad, S., and Aggarwal, B. B. ( 2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 11, 495–510.
- 4 Sarkar, F. H., Li, Y., Wang, Z., and Padhye, S. ( 2010) Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Curr. Pharm. Des. 16, 1801–1812.
- 5 Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., and Aggarwal, B. B. ( 2008) Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 267, 133–164.
- 6 Hatcher, H., Planalp, R., Cho, J., Torti, F. M., and Torti, S. V. ( 2008) Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life. Sci. 65, 1631–1652.
- 7 Strimpakos, A. S. and Sharma, R. A. ( 2008) Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox. Signal. 10, 511–545.
- 8 Gupta, S. C., Prasad, S., Kim, J. H., Patchva, S., Webb, L. J., et al. ( 2011) Multitargeting by curcumin as revealed by molecular interaction studies. Nat. Prod. Rep. 28, 1937–1955.
- 9 Shehzad, A. and Lee, Y. S. ( 2010) Curcumin: multiple molecular targets mediate multiple pharmacological actions: a review. Drugs Fut. 35, 113–119.
- 10 Ramachandran, C., Rodriguez, S., Ramachandran, R, Raveendran Nair, P. K., Fonseca, H., et al. ( 2005) Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 25, 3293–3302.
- 11 Roy, M., Chakraborty, S., Siddiqi, M., and Bhattacharya, R. K. ( 2002) Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pac. J. Cancer Prev. 3, 61–67.
- 12 Ashkenazi, A., Holland, P., and Eckhardt, S. G. ( 2008) Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J. Clin. Oncol. 26, 3621–3630.
- 13 Marciniak, S. J. and Ron, D. ( 2006) Endoplasmic reticulum stress signaling in disease. Physiol. Rev. 86, 1133–1149.
- 14 Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., et al. ( 2008) Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 27, 285–299.
- 15 Lin, S. S., Huang, H. P., Yang, J. S., Wu, J. Y., Hsia, T. C., et al. ( 2008) DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway. Cancer Lett. 272, 77–90.
- 16 Wu, S. H., Hang, L. W., Yang, J. S., Chen, H. Y., Lin, H. Y., et al. ( 2010) Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res. 30, 2125–2133.
- 17 Wang, W. H., Chiang, I. T., Ding, K., Chung, J. G., Lin, W. J., et al. ( 2012) Curcumin-induced apoptosis in human hepatocellular carcinoma j5 cells: critical role of Ca(+2)-dependent pathway. Evid. Based. Complement. Alternat. Med. 2012, 512907.
- 18 Wang, L., Wang, L., Song, R., Shen, Y., Sun, Y., et al. ( 2011) Targeting sarcoplasmic/endoplasmic reticulum Caȧ+-ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma. Mol. Cancer Ther. 10, 461–471.
- 19 Guo, L. D., Chen, X. J., Hu, Y. H., Yu, Z. J., Wang, D., et al. Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother. Res., in press.
- 20 Woo, J. H., Kim, Y. H., Choi, Y. J., Kim, D. G., Lee, K. S., et al. ( 2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 24, 1199–1208.
- 21 Bush, J. A., Cheung, K. J., and Li, G. ( 2001) Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell. Res. 271, 305–314.
- 22 Volate, S. R., Davenport, D. M., Muga, S. J., and Wargovich, M. J. ( 2005) Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis. 26, 1450–1456.
- 23 Bossen, C., Ingold, K., Tardivel, A., Bodmer, J. L., Gaide, O., et al. ( 2006) Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J. Biol. Chem. 281, 13964–13971.
- 24 Lee, H. P., Li, T. M., Tsao, J. Y., Fong, Y. C., and Tang, C. H. ( 2012) Curcumin induces cell apoptosis in human chondrosarcoma through extrinsic death receptor pathway. Int. Immunopharmacol. 13, 163–169.
- 25 Shankar, S., Chen, Q., Sarva, K., Siddiqui, I., and Srivastava, R. K. ( 2007) Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis. J. Mol. Signal. 2, 10.
- 26 Anto, R. J., Mukhopadhyay, A., Denning, K., and Aggarwal, B. B. ( 2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23, 143–150.
- 27 Piwocka, K., Jaruga, E., Skierski, J., Gradzka, I., and Sikora, E. ( 2001) Effect of glutathione depletion on caspase-3 independent apoptosis pathway induced by curcumin in Jurkat cells. Free. Radic. Biol. Med. 31, 670–678.
- 28 Rashmi, M. R., Santhosh Kumar, M. T. R., and Karunagaran, D. ( 2003) Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett. 538, 19–24.
- 29 Song, K., Peng, S., Sun, Z., Li, H., and Yang, R. ( 2011) Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts. Biochem. Biophys. Res. Commun. 411, 821–825.
- 30 Erster, S., Mihara, M., Kim, R. H., Petrenko, O., and Moll, U. M. ( 2004) In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol. Cell. Biol. 24, 6728–6741.
- 31 Harris, S. L. and Levine, A. J. ( 2005) The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899–2908.
- 32 Moos, P. J., Edes, K., Mullally, J. E., and Fitzpatrick, F. A. ( 2004) Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25, 1611–1617.
- 33 Su, C. C., Wang, M. J., and Chiu, T. L. ( 2010) The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma. Int. J. Mol. Med. 26, 217–224.
- 34 Liontas, A. and Yeger, H. ( 2004) Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res. 24, 987–998.
- 35 Shieh, S. Y., Ikeda, M., Taya, Y., and Prives, C. ( 1997) DNA damage induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325–334.
- 36 Imamura, K., Ogura, T., Kishimoto, A., Kaminishi, M., and Esumi, H. ( 2001) Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole-4- carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 287, 562–567.
- 37 Pan, W., Yang, H., Cao, C., Song, X., Wallin, B., et al. ( 2008) AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells. Oncol. Rep. 20, 1553–1559.
- 38 Watson, J. L., Hill, R., Yaffe, P. B., Greenshields, A., Walsh, M., et al. ( 2010) Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett. 297, 1–8.
- 39 Wang, M. E., Chen, Y. C., Chen, I. S., Hsieh, S. C., Chen, S. S., et al. Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes. J. Nutr. Biochem., in press.
- 40 He, Z. Y., Shi, C. B., Wen, H., Li, F. L., Wang, B. L., et al. ( 2011) Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. 29, 208–213.
- 41 Aggarwal, S., Takada, Y., Singh, S., Myers, J. N., and Aggarwal, B. B. ( 2004) Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int. J. Cancer. 111, 679–692.
- 42 Chakravarti, N., Kadara, H., Yoon, D. J., Shay, J. W., Myers, J. N., et al. ( 2010) Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells. Cancer Prev. Res. (Phila). 3, 331–338.
- 43 Chang, K. W., Hung, P. S., Lin, I. Y., Hou, C. P., Chen, L. K., et al. ( 2010) Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression. Int. J. Cancer. 127, 9–20.
- 44 Yao, J., Duan, L., Fan, M., and Wu, W. ( 2007) Gamma-secretase inhibitors exerts antitumor activity via down-regulation of Notch and Nuclear factor kappa B in human tongue carcinoma cells. Oral Dis. 13, 555–563.
- 45 Shin, H. K., Kim, J., Lee, E. J., and Kim, S. H. ( 2010) Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD-10B cells via suppression of ERK and NF-kappaB activations. Phytother. Res. 24, 577–582.
- 46 Hayden, M. S. and Ghosh, S. ( 2004) Signaling to NF-kappaB. Genes Dev. 18, 2195–2224.
- 47 Bharti, A. C., Donato, N., Singh, S., and Aggarwal, B. B. ( 2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 101, 1053–1062.
- 48 Khan, S., Shehzad, O., Jin, H. G., Woo, E. R., Kang, S. S., et al. ( 2012) Anti-inflammatory mechanism of 15,16-epoxy-3alpha-hydroxylabda-8,13(16),14-trien-7-one via inhibition of LPS-induced multicellular signaling pathways. J. Nat. Prod. 75, 67–71.
- 49 Kong, A. N., Yu, R., Hebbar, V., Chen, C., Owuor, E., et al. ( 2001) Signal transduction events elicited by cancer prevention compounds. Mutat. Res. 480–481, 231–241.
- 50 Zhou, Y., Zheng, S., Lin, J., Zhang, Q. J., and Chen, A. ( 2007) The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab. Invest. 87, 488–498.
- 51 Chun, K. S., Keum, Y. S., Han, S. S., Song, Y. S., Kim, S. H., et al. ( 2003) Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 24, 1515–1524.
- 52 Salh, B., Assi, K., Templeman, V., Parhar, K., Owen, D., et al. ( 2003) Curcumin attenuates DNB-induced murine colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 285, 235–243.
- 53 Soetikno, V., Sari, F. R., Sukumaran, V., Lakshmanan, A. P., Mito, S., et al. ( 2012) Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: Possible involvement of PKC-MAPK signaling pathway. Eur. J Pharm. Sci. 47, 604–614.
- 54 Shehzad, A., Khan, S., Shehzad, O., and Lee, Y. S. Curcumin therapeutic promises and bioavailability in colorectal cancer. Drugs Today (Barc) 46, 523–532.
- 55 Clarke, R. B. ( 2003) p27KIP1 phosphorylation by PKB/Akt leads to poor breast cancer prognosis. Breast. Cancer. Res. 5, 162–163.
- 56 Yu, S., Shen, G., Khor, T. O., Kim, J. H., and Kong, A. N. ( 2008) Curcumin inhibits Akt/mTOR signaling through protein phosphatase-dependent mechanism. Mol. Cancer Ther. 7, 2609–2620.
- 57 Lee, Y. K., Park, S. Y., Kim, Y. M., and Park, O. J. ( 2009) Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann. N Y Acad. Sci. 1171, 489–494.
- 58 Squires, M. S., Hudson, E. A., Howells, L., Sale, S, Houghton, C. E., et al. ( 2003) Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem. Pharmacol. 65, 361–376.
- 59 Deeb, D., Jiang, H., Gao, X., Al-Holou, S., Danyluk, A. L., et al. ( 2007) Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1–6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. J. Pharmacol. Exp. Ther. 321, 616–625.
- 60 Wang, H., Geng, Q. R., Wang, L., and Lu, Y. Curcumin potentiates antitumor activity of l-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia. Leuk. Lymphoma. 53, 1376–1382.
- 61 Sun, Z., Zhang, S., Chan, J. Y., and Zhang, D. D. ( 2007) Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell. Biol. 27, 6334–6349.
- 62 Wang, Z., Li, Y., Banerjee, S., and Sarkar, F. H. ( 2008) Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res. 28, 3621–3630.
- 63 Liao, S., Xia, J., Chen, Z., Zhang, S., Ahmad, A., et al. ( 2011) Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways. J. Cell. Biochem. 112, 1055–1065.
- 64 Joo, Y. H., Jung C. K., Kim M. S., and Sun, D. I. ( 2009) Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer. Otolaryngol. Head. Neck Surg. 140, 512–518.
- 65 Subramaniam, D., Ponnurangam, S., Ramamoorthy, P., Standing, D., Battafarano, R. J., et al. ( 2012) Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One 7, e30590.
- 66 Wang, Z., Zhang. Y., Banerjee, S., Li, Y., and Sarkar, F. H. ( 2006) Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106, 2503–25013.
- 67 Li, Y., Zhang, J., Ma, D., Zhang, L., Si, M., et al. ( 2012) Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS J. 279, 2247–2259.
- 68 Hybertson, B. M., Gao, B., Bose, S. K., and McCord, J. M. ( 2011) Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol. Aspects Med. 32, 234–246.
- 69 Kansanen, E., Jyrkkänen, H. K., and Levonen, A. L. ( 2012) Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids. Free Radic. Biol. Med. 52, 973–982.
- 70 Panchal, H. D., Vranizan, K., Lee, C. Y., Ho, J., Ngai, J., et al. ( 2008) Early anti-oxidative and anti-proliferative curcumin effects on neuroglioma cells suggest therapeutic targets. Neurochem. Res. 33, 1701–1710.
- 71 Shehzad, A., Ha, T., Subhan, F., and Lee, Y. S. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur. J. Nutr. 50, 151–161.
- 72 Tapia, E., Soto, V., Ortiz-Vega, K. M., Zarco-Márquez, G., Molina-Jijón, E., et al. ( 2012) Curcumin induces nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats. Oxid. Med. Cell. Longev. 2012, 269039.
- 73 He, H. J., Wang, G. Y., Gao, Y., Ling, W. H., Yu, Z.W., et al. ( 2012) Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World J. Diabetes 3, 94–104.
- 74 Zhao, S. G., Li, Q., Liu, Z. X., Wang, J. J., Wang, X. X., et al. ( 2011) Curcumin attenuates insulin resistance in hepatocytes by inducing Nrf2 nuclear translocation. Hepatogastroenterology 58, 2106–2111.
- 75 Westendorf, J. J., Kahler, R. A., and Schroeder, T. M. ( 2004) Wnt signaling in osteoblasts and bone diseases. Gene 341, 19–39.
- 76 Gandhirajan, R. K., Poll-Wolbeck, S. J., Gehrke, I., and Kreuzer, K. A. ( 2010) Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options. Curr. Cancer Drug Targets 10, 716–727.
- 77 Day, T. F., Guo, X., Garrett-Beal, L., and Yang, Y. ( 2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739–750.
- 78 Prasad, C. P., Rath, G., Mathur, S., Bhatnagar, D., and Ralhan, R. ( 2009) Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling. Chem. Biol. Interact. 181, 263–271.
- 79 Sundram, V., Chauhan, S. C., Ebeling, M., and Jaggi, M. ( 2012) Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1. PLoS One 7, e35368.
- 80 Dell'Albani, P., Santangelo, R., Torrisi, L., Nicoletti, V. G., de Vellis, J., et al. ( 2001) JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J. Neurosci. Res. 65, 417–424.
- 81 Kovarik, P., Mangold, M., Ramsauer, K., Heidari, H., Steinborn, R., et al. ( 2001) Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20, 91–100.
- 82 Cull, V. S., Tilbrook, P. A, Bartlett, E. J., Brekalo, N. L., and James, C. M. ( 2003) Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood 101, 2727–2735.
- 83 Krebs, D. L. and Hilton, D. J. ( 2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19, 378–387.
- 84 Kim, O. S., Park, E. J., Joe, E. H., and Jou, I. ( 2002) JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J. Biol. Chem. 277, 40594–40601.
- 85 Kim, H. Y., Park E. J., Joe E. H., and Jou, I. ( 2003) Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J. Immunol. 171, 6072–6079.
- 86 Seo, J. H., Jeong, K. J., Oh, W. J., Sul, H. J., Sohn, J. S., et al. ( 2010) Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin. Cancer Lett. 288, 50–56.
- 87 Duan, W., Yang, Y., Yan, J., Yu, S., Liu, J., et al. ( 2012) The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway. Basic. Res. Cardiol. 107, 263.
- 88 Wegrzyn, J., Potla, R., Chwae, Y. J., Sepuri, N. B., Zhang, Q., et al. ( 2009) Function of mitochondrial Stat3 in cellular respiration. Science 323, 793–797.
- 89 Wang, L., Li, C., Guo, H., Kern, T. S., Huang, K., et al. ( 2011) Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury. PLoS One 6, e23194.
- 90 Kahn, B. B., Alquier, T., Carling, D., and Hardie, D. G. ( 2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell. Metab. 1, 15–25.
- 91 Wang, S., Song, P., and Zou, M. H. ( 2012) AMP-activated protein kinase, stress responses and cardiovascular diseases. Clin. Sci. (Lond) 122, 555–573.
- 92 Hwang, J. T., Kim, Y. M., Surh, Y. J., Baik, H. W., Lee, S. K., et al. ( 2006) Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells. Cancer Res. 66, 10057–10063.
- 93 Salminen, A., Hyttinen, J. M., and Kaarniranta, K. ( 2011) AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. (Berl) 89, 667–676.
- 94 Zhang, H. S., Ruan, Z., and Sang, W. W. ( 2011) HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation. J. Cell. Physiol. 226, 3385–3391.
- 95 Lee, Y. K., Lee, W. S., Hwang, J. T., Kwon, D. Y., Surh, Y. J., et al. ( 2009) Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J. Agric. Food. Chem. 57, 305–310.
- 96 Kubota, M., Shimizu, M., Sakai, H., Yasuda, Y., Terakura, D., et al. ( 2012) Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice. Nutr. Cancer 64, 72–79.
- 97 Jung, Y., Xu, W., Kim, H., Ha, N., and Neckers, L. ( 2007) Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin. Biochim. Biophys. Acta. 1773, 383–390.
- 98 Cai, W., Zhang, B., Duan, D., Wu, J., and Fang, J. ( 2012) Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells. Toxicol. Appl. Pharmacol. 262, 341–348.
- 99 Liu, M., Yuan, M., Luo, M., Bu, X., Luo, H. B., et al. ( 2010) Binding of curcumin with glyoxalase I: Molecular docking, molecular dynamics simulations, and kinetics analysis. Biophys. Chem. 147, 28–34.
- 100 Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., et al. ( 2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279, 51163–1171.
Citing Literature
